Name: | NOVARTIS CORPORATION |
Jurisdiction: | New York |
Legal type: | DOMESTIC BUSINESS CORPORATION |
Status: | Active |
Date of registration: | 15 Nov 1966 (58 years ago) |
Entity Number: | 203887 |
ZIP code: | 12207 |
County: | New York |
Place of Formation: | New York |
Address: | 80 State Street, Albany, NY, United States, 12207 |
Principal Address: | One Health Plaza, East Hanover, NJ, United States, 07936 |
Shares Details
Shares issued 805000
Share Par Value 0
Type NO PAR VALUE
Type | Company Name | Company Number | State |
---|---|---|---|
Headquarter of | NOVARTIS CORPORATION, CONNECTICUT | 1215825 | CONNECTICUT |
Plan Name | Plan Year | EIN/PN | Received | Sponsor | Total number of participants | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVARTIS CORPORATION DEATH BENEFIT AND DISABILITY PLAN | 2012 | 131834433 | 2013-10-11 | NOVARTIS CORPORATION | 15009 | |||||||||||||||||||||||||||||||||||||
|
Active participants | 11400 |
Retired or separated participants receiving benefits | 2202 |
Signature of
Role | Plan administrator |
Date | 2013-10-15 |
Name of individual signing | DAN COLUMBUS |
Valid signature | Filed with authorized/valid electronic signature |
File | View Page |
Three-digit plan number (PN) | 541 |
Effective date of plan | 2011-01-01 |
Business code | 325410 |
Sponsor’s telephone number | 8627788300 |
Plan sponsor’s mailing address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan sponsor’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Number of participants as of the end of the plan year
Retired or separated participants receiving benefits | 5635 |
Other retired or separated participants entitled to future benefits | 3186 |
Signature of
Role | Plan administrator |
Date | 2013-10-15 |
Name of individual signing | DAN COLUMBUS |
Valid signature | Filed with authorized/valid electronic signature |
File | View Page |
Three-digit plan number (PN) | 540 |
Effective date of plan | 2010-01-01 |
Business code | 325410 |
Sponsor’s telephone number | 8627788300 |
Plan sponsor’s mailing address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan sponsor’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Number of participants as of the end of the plan year
Active participants | 16849 |
Retired or separated participants receiving benefits | 2182 |
Signature of
Role | Plan administrator |
Date | 2013-10-15 |
Name of individual signing | DAN COLUMBUS |
Valid signature | Filed with authorized/valid electronic signature |
File | View Page |
Three-digit plan number (PN) | 543 |
Effective date of plan | 2012-01-01 |
Business code | 325410 |
Sponsor’s telephone number | 8627788300 |
Plan sponsor’s mailing address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan sponsor’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Number of participants as of the end of the plan year
Active participants | 1980 |
Signature of
Role | Plan administrator |
Date | 2013-10-15 |
Name of individual signing | DAN COLUMBUS |
Valid signature | Filed with authorized/valid electronic signature |
File | View Page |
Three-digit plan number (PN) | 542 |
Effective date of plan | 2011-01-01 |
Business code | 325410 |
Sponsor’s telephone number | 8627788300 |
Plan sponsor’s mailing address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan sponsor’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan administrator’s name and address
Administrator’s EIN | 131834433 |
Plan administrator’s name | NOVARTIS CORPORATION |
Plan administrator’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Administrator’s telephone number | 8627788300 |
Number of participants as of the end of the plan year
Active participants | 11758 |
Retired or separated participants receiving benefits | 2127 |
Signature of
Role | Plan administrator |
Date | 2012-10-15 |
Name of individual signing | DAN COLUMBUS |
Valid signature | Filed with authorized/valid electronic signature |
File | View Page |
Three-digit plan number (PN) | 540 |
Effective date of plan | 2010-01-01 |
Business code | 325410 |
Sponsor’s telephone number | 8627788300 |
Plan sponsor’s mailing address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan sponsor’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan administrator’s name and address
Administrator’s EIN | 131834433 |
Plan administrator’s name | NOVARTIS CORPORATION |
Plan administrator’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Administrator’s telephone number | 8627788300 |
Number of participants as of the end of the plan year
Active participants | 18705 |
Retired or separated participants receiving benefits | 1871 |
Signature of
Role | Plan administrator |
Date | 2012-10-15 |
Name of individual signing | DAN COLUMBUS |
Valid signature | Filed with authorized/valid electronic signature |
File | View Page |
Three-digit plan number (PN) | 541 |
Effective date of plan | 2011-01-01 |
Business code | 325410 |
Sponsor’s telephone number | 8627788300 |
Plan sponsor’s mailing address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan sponsor’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Plan administrator’s name and address
Administrator’s EIN | 131834433 |
Plan administrator’s name | NOVARTIS CORPORATION |
Plan administrator’s address | 608 FIFTH AVENUE, NEW YORK, NY, 100202303 |
Administrator’s telephone number | 8627788300 |
Number of participants as of the end of the plan year
Retired or separated participants receiving benefits | 5635 |
Other retired or separated participants entitled to future benefits | 2245 |
Signature of
Role | Plan administrator |
Date | 2012-10-15 |
Name of individual signing | DAN COLUMBUS |
Valid signature | Filed with authorized/valid electronic signature |
Name | Role | Address |
---|---|---|
THE PRENTICE-HALL CORPORATION SYSTEM | Agent | 80 STATE STREET, ALBANY, NY, 12207 |
Name | Role | Address |
---|---|---|
C/O THE PRENTICE-HALL CORPORATION SYSTEM INC | DOS Process Agent | 80 State Street, Albany, NY, United States, 12207 |
Name | Role | Address |
---|---|---|
JOHN MCKENNA | Chief Executive Officer | ONE HEALTH PLAZA, EAST HANOVER, NJ, United States, 07936 |
Start date | End date | Type | Value |
---|---|---|---|
2024-11-01 | 2024-11-01 | Address | ONE HEALTH PLAZA, EAST HANOVER, NJ, 07936, USA (Type of address: Chief Executive Officer) |
2024-11-01 | 2024-11-01 | Address | ONE SOUTH RIDGEDALE AVE, BLDG 122, EAST HANOVER, NJ, 07936, USA (Type of address: Chief Executive Officer) |
2024-10-25 | 2024-11-01 | Shares | Share type: PAR VALUE, Number of shares: 88925455, Par value: 1 |
2023-05-19 | 2024-10-25 | Shares | Share type: PAR VALUE, Number of shares: 88925455, Par value: 1 |
2023-05-05 | 2023-05-19 | Shares | Share type: PAR VALUE, Number of shares: 88925455, Par value: 1 |
2022-11-03 | 2023-05-05 | Shares | Share type: PAR VALUE, Number of shares: 88925455, Par value: 1 |
2022-06-24 | 2022-11-03 | Shares | Share type: PAR VALUE, Number of shares: 88925455, Par value: 1 |
2021-09-28 | 2022-06-24 | Shares | Share type: PAR VALUE, Number of shares: 88925455, Par value: 1 |
2020-11-02 | 2024-11-01 | Address | 80 STATE STREET, ALBANY, NY, 12207, USA (Type of address: Service of Process) |
2016-11-01 | 2024-11-01 | Address | ONE SOUTH RIDGEDALE AVE, BLDG 122, EAST HANOVER, NJ, 07936, USA (Type of address: Chief Executive Officer) |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
241101034782 | 2024-11-01 | BIENNIAL STATEMENT | 2024-11-01 |
221116001673 | 2022-11-16 | BIENNIAL STATEMENT | 2022-11-01 |
201102062020 | 2020-11-02 | BIENNIAL STATEMENT | 2020-11-01 |
181101006172 | 2018-11-01 | BIENNIAL STATEMENT | 2018-11-01 |
161101006793 | 2016-11-01 | BIENNIAL STATEMENT | 2016-11-01 |
141104006846 | 2014-11-04 | BIENNIAL STATEMENT | 2014-11-01 |
131120002019 | 2013-11-20 | AMENDMENT TO BIENNIAL STATEMENT | 2012-11-01 |
131001002075 | 2013-10-01 | AMENDMENT TO BIENNIAL STATEMENT | 2012-11-01 |
121102006037 | 2012-11-02 | BIENNIAL STATEMENT | 2012-11-01 |
110623001109 | 2011-06-23 | CERTIFICATE OF AMENDMENT | 2011-06-23 |
Mark | US Serial Number | Application Filing Date | US Registration Number | Registration Date | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ESTRADERM | 73431955 | 1983-06-27 | 1284942 | 1984-07-10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Mark Literal Elements | ESTRADERM |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | Hormone Deficiency Preparation |
International Class(es) | 005 - Primary Class |
U.S Class(es) | 018 |
Class Status | SECTION 8 - CANCELLED |
First Use | May 16, 1983 |
Use in Commerce | May 16, 1983 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | Novartis Corporation |
Owner Address | 608 Fifth Avenue New York, NEW YORK UNITED STATES 10020 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | ADAM R. AGENSKY |
Fax | 919-861-8913 |
Phone | 919-861-8903 |
Correspondent e-mail | mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper, III, Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2015-11-04 | CANCELLED SEC. 8 (10-YR) |
2010-04-06 | CASE FILE IN TICRS |
2009-09-26 | REVIEW OF CORRESPONDENCE COMPLETE |
2009-06-17 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
2004-09-01 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
2004-09-01 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2004-06-24 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
2004-06-24 | TEAS SECTION 8 & 9 RECEIVED |
1990-07-28 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
1990-05-18 | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
1984-07-10 | REGISTERED-PRINCIPAL REGISTER |
1984-04-17 | PUBLISHED FOR OPPOSITION |
1984-03-05 | NOTICE OF PUBLICATION |
1984-01-23 | APPROVED FOR PUB - PRINCIPAL REGISTER |
1984-01-06 | ASSIGNED TO EXAMINER |
TM Staff and Location Information
Current Location | POST REGISTRATION |
Date in Location | 2015-11-04 |
Register | Principal |
Mark Type | Trademark |
Status | Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Status Date | 2021-10-15 |
Publication Date | 1981-01-06 |
Date Cancelled | 2021-10-15 |
Mark Information
Mark Literal Elements | RITALIN SR |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | Pharmaceutical Preparation Having a Stimulating Effect |
International Class(es) | 005 - Primary Class |
U.S Class(es) | 018 |
Class Status | SECTION 8 - CANCELLED |
Basis | 1(a) |
First Use | Jan. 25, 1979 |
Use in Commerce | Jan. 25, 1979 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | Maury M. Tepper, III |
Attorney Email Authorized | Yes |
Attorney Primary Email Address | mtepper@teiplaw.com |
Fax | 919-861-8913 |
Phone | 919-861-8903 |
Correspondent e-mail | mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper, III, TEPPER & EYSTER, PLLC, 3724 BENSON DRIVE, RALEIGH, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2021-10-15 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
2020-03-31 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2011-04-01 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2011-04-01 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2011-03-30 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2011-03-29 | TEAS SECTION 8 & 9 RECEIVED |
2009-10-16 | REVIEW OF CORRESPONDENCE COMPLETE |
2009-06-26 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2009-06-26 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2008-02-29 | CASE FILE IN TICRS |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
2001-07-19 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
2001-07-19 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2001-04-24 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
1996-10-26 | REGISTERED - SEC. 15 ACKNOWLEDGED |
1996-09-09 | REGISTERED - SEC. 15 AFFIDAVIT FILED |
1987-08-31 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
1987-03-13 | REGISTERED - SEC. 8 (6-YR) FILED |
1981-03-31 | REGISTERED-PRINCIPAL REGISTER |
1981-01-06 | PUBLISHED FOR OPPOSITION |
TM Staff and Location Information
Current Location | GENERIC WEB UPDATE |
Date in Location | 2011-04-01 |
Register | Principal |
Mark Type | Trademark |
Status | This registration was not renewed and therefore has expired. |
Status Date | 2009-06-13 |
Mark Information
Mark Literal Elements | CONCEP |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | SORGHUM LIQUID SEED SAFENER |
International Class(es) | 001 - Primary Class |
U.S Class(es) | 006 |
Class Status | EXPIRED |
Basis | 1(a) |
First Use | Feb. 04, 1978 |
Use in Commerce | Feb. 04, 1978 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 079011027 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Correspondent Name/Address | CHRIS DONINGER, NOVARTIS CORPORATION, 564 MORRIS AVE, SUMMIT, NEW JERSEY UNITED STATES 07901-1027 |
Prosecution History
Date | Description |
---|---|
2009-06-13 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
2008-01-04 | CASE FILE IN TICRS |
2000-03-20 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
2000-03-20 | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 |
1998-10-30 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1998-10-30 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1998-10-30 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1998-10-30 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1984-09-26 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
1984-07-12 | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
TM Staff and Location Information
Current Location | SCANNING ON DEMAND |
Date in Location | 2008-01-04 |
Register | Principal |
Mark Type | Trademark |
Status | This registration was not renewed and therefore has expired. |
Status Date | 2007-11-17 |
Mark Information
Mark Literal Elements | APRESAZIDE |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | ANTIHYPERTENSIVE |
International Class(es) | 005 - Primary Class |
U.S Class(es) | 018 |
Class Status | EXPIRED |
First Use | Jun. 11, 1976 |
Use in Commerce | Jun. 11, 1976 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Fax | 919-861-8913 |
Phone | 919-861-8903 |
Correspondent e-mail | mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper, III, Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2009-06-17 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2007-11-17 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
2007-11-08 | CASE FILE IN TICRS |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
1999-09-29 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
1998-11-18 | RESPONSE RECEIVED TO POST REG. ACTION |
1998-11-02 | POST REGISTRATION ACTION MAILED - SEC. 9 |
1997-10-28 | RESPONSE RECEIVED TO POST REG. ACTION |
1997-05-09 | POST REGISTRATION ACTION MAILED - SEC. 9 |
1997-02-13 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1982-05-17 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
TM Staff and Location Information
Current Location | SCANNING ON DEMAND |
Date in Location | 2007-11-08 |
Register | Principal |
Mark Type | Trademark |
Status | Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Status Date | 2020-03-16 |
Date Cancelled | 2020-03-16 |
Mark Information
Mark Literal Elements | CYTADREN |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | AMINOGLUTETHIMIDE |
International Class(es) | 005 - Primary Class |
U.S Class(es) | 018 |
Class Status | SECTION 8 - CANCELLED |
Basis | 1(a) |
First Use | Apr. 27, 1976 |
Use in Commerce | Apr. 27, 1976 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | MAURY M. TEPPER, III |
Docket Number | 51653.277.1 |
Fax | 919-861-8913 |
Phone | 919-861-8903 |
Correspondent e-mail | mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper, III, Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2020-03-16 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
2016-01-18 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2009-12-07 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2007-11-02 | CASE FILE IN TICRS |
2006-10-20 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2006-10-20 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2006-10-03 | ASSIGNED TO PARALEGAL |
2006-07-17 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
2006-07-17 | TEAS SECTION 8 & 9 RECEIVED |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
1996-12-17 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
1996-10-28 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1982-08-02 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
TM Staff and Location Information
Current Location | SCANNING ON DEMAND |
Date in Location | 2007-11-02 |
Register | Principal |
Mark Type | Trademark |
Status | The registration has been renewed. |
Status Date | 2023-07-17 |
Mark Information
Mark Literal Elements | VOLTAREN |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | ANTIPHLOGISTIC AND ANTIRHEUMATIC |
International Class(es) | 005 |
U.S Class(es) | 018 - Primary Class |
Class Status | ACTIVE |
Basis | 44(e) |
Basis Information (Case Level)
Filed Use | No |
Currently Use | No |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | Yes |
Currently 44E | Yes |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 608 FIFTH AVENUE NEW YORK, NEW YORK UNITED STATES 10020 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | Maury M. Tepper, III |
Attorney Email Authorized | Yes |
Attorney Primary Email Address | mtepper@teiplaw.com |
Fax | 9198618913 |
Phone | 9198618903 |
Correspondent e-mail | athompson@teiplaw.com, mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper, III, Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2023-07-18 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
2023-07-17 | REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS) |
2023-07-17 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2023-07-17 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2022-12-26 | TEAS SECTION 8 & 9 RECEIVED |
2022-06-05 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2014-03-26 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2014-03-12 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2013-03-01 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
2013-03-01 | REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) |
2013-03-01 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2013-03-01 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2013-02-18 | TEAS SECTION 8 & 9 RECEIVED |
2011-07-20 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2011-07-13 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2010-12-22 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2010-12-15 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2010-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2010-01-22 | REVIEW OF CORRESPONDENCE COMPLETE |
2010-01-22 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2009-12-02 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2009-06-17 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2008-09-02 | CASE FILE IN TICRS |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
2003-08-04 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2003-08-04 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2003-05-22 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
2003-05-21 | TEAS SECTION 8 & 9 RECEIVED |
1996-10-28 | REGISTERED - SEC. 15 ACKNOWLEDGED |
1996-09-09 | REGISTERED - SEC. 15 AFFIDAVIT FILED |
1993-10-27 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
1993-09-07 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1979-06-04 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
TM Staff and Location Information
Current Location | GENERIC WEB UPDATE |
Date in Location | 2023-07-17 |
Register | Principal |
Mark Type | Trademark |
Status | The registration has been renewed. |
Status Date | 2015-04-16 |
Mark Information
Mark Literal Elements | TEGRETOL |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | ANTI-EPILEPTIC PREPARATION |
International Class(es) | 005 |
U.S Class(es) | 018 - Primary Class |
Class Status | ACTIVE |
Basis | 1(a) |
First Use | Aug. 31, 1964 |
Use in Commerce | Aug. 31, 1964 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | Maury M. Tepper, III |
Attorney Email Authorized | Yes |
Attorney Primary Email Address | mtepper@teiplaw.com |
Fax | 9198618913 |
Phone | 9198618903 |
Correspondent e-mail | mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper, III, Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2024-04-13 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2015-04-16 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
2015-04-16 | REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) |
2015-04-16 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2015-04-09 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2015-03-26 | TEAS SECTION 8 & 9 RECEIVED |
2009-12-07 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2005-06-10 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2005-06-10 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2005-06-10 | ASSIGNED TO PARALEGAL |
2005-04-12 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
2005-04-12 | TEAS SECTION 8 & 9 RECEIVED |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
1985-04-13 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
1985-02-19 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
TM Staff and Location Information
Current Location | GENERIC WEB UPDATE |
Date in Location | 2015-04-16 |
Register | Principal |
Mark Type | Trademark |
Status | Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Status Date | 2020-03-16 |
Date Cancelled | 2020-03-16 |
Mark Information
Mark Literal Elements | PILOCAR |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | Ophthalmic Solution |
International Class(es) | 005 |
U.S Class(es) | 018 - Primary Class |
Class Status | SECTION 8 - CANCELLED |
Basis | 1(a) |
First Use | Jan. 1962 |
Use in Commerce | Jan. 1962 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 608 FIFTH AVENUE NEW YORK, NEW YORK UNITED STATES 10020 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Correspondent Name/Address | STEVEN H HARTMAN, NOVARTIS, ONE HEALTH PLZ BLDG 430, EAST HANOVER, NEW JERSEY UNITED STATES 79361080 |
Prosecution History
Date | Description |
---|---|
2020-03-16 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
2005-12-31 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2005-12-31 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2005-04-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2004-10-12 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
2004-06-28 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
2004-06-28 | TEAS SECTION 8 & 9 RECEIVED |
1984-12-04 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
1984-09-19 | RESPONSE RECEIVED TO POST REG. ACTION |
1984-09-06 | POST REGISTRATION ACTION MAILED - SEC. 9 |
1984-06-22 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
TM Staff and Location Information
Current Location | POST REGISTRATION |
Date in Location | 2005-12-31 |
Register | Principal |
Mark Type | Trademark |
Status | The registration has been renewed. |
Status Date | 2022-06-20 |
Mark Information
Mark Literal Elements | DESFERAL |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | Pharmaceutical Preparation for the Treatment of Diseases Involving Pathological Deposition of Iron |
International Class(es) | 005 |
U.S Class(es) | 018 - Primary Class |
Class Status | ACTIVE |
Basis | 44(e) |
Basis Information (Case Level)
Filed Use | No |
Currently Use | No |
Filed ITU | No |
Currently ITU | No |
Filed 44D | Yes |
Currently 44D | No |
Filed 44E | No |
Currently 44E | Yes |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 Morris Avenue Summit, NEW JERSEY UNITED STATES 07901 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | Maury M. Tepper III |
Attorney Email Authorized | Yes |
Attorney Primary Email Address | mtepper@teiplaw.com |
Fax | 919-861-8913 |
Phone | 919-861-8903 |
Correspondent e-mail | athompson@teiplaw.com, mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper III, TEPPER & EYSTER, PLLC, 3724 BENSON DRIVE, RALEIGH, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2022-06-20 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
2022-06-20 | REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS) |
2022-06-20 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2022-06-20 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2022-01-17 | TEAS SECTION 8 & 9 RECEIVED |
2021-09-04 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2013-03-04 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2013-03-04 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2012-06-23 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
2012-06-23 | REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) |
2012-06-23 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2012-06-23 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2012-06-14 | TEAS SECTION 8 & 9 RECEIVED |
2009-11-10 | REVIEW OF CORRESPONDENCE COMPLETE |
2009-06-18 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2008-10-29 | CASE FILE IN TICRS |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
2002-11-25 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2002-11-25 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2002-09-04 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
2002-09-04 | TEAS SECTION 8 & 9 RECEIVED |
1984-10-25 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
1982-09-04 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
1982-09-04 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
TM Staff and Location Information
Current Location | GENERIC WEB UPDATE |
Date in Location | 2022-06-20 |
Register | Principal |
Mark Type | Trademark |
Status | Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Status Date | 2016-04-01 |
Date Cancelled | 2016-04-01 |
Mark Information
Mark Literal Elements | INFLAMASE |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | Anti-Inflammatory and Anti-Edematous Enzyme Preparation |
International Class(es) | 005 |
U.S Class(es) | 018 - Primary Class |
Class Status | SECTION 8 - CANCELLED |
Basis | 1(a) |
First Use | Jul. 1960 |
Use in Commerce | Jul. 1960 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | STEVEN H. HARTMAN |
Correspondent Name/Address | STEVEN H HARTMAN, NOVARTIS PHARMACEUTICALS CORPORATION, 564 MORRIS AVE, SUMMIT, NEW JERSEY UNITED STATES 09701 |
Prosecution History
Date | Description |
---|---|
2016-04-01 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
2008-10-24 | CASE FILE IN TICRS |
2001-08-21 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2001-08-21 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2001-05-24 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
1984-10-25 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
1981-05-16 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
1981-05-16 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
TM Staff and Location Information
Current Location | SCANNING ON DEMAND |
Date in Location | 2008-10-24 |
Register | Principal |
Mark Type | Trademark |
Status | This registration was not renewed and therefore has expired. |
Status Date | 2010-04-10 |
Mark Information
Mark Literal Elements | DACRIOSE |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | STERILE OPHTHALMIC IRRIGATING SOLUTIONS |
International Class(es) | 005 |
U.S Class(es) | 018 - Primary Class |
Class Status | EXPIRED |
Basis | 1(a) |
First Use | Mar. 18, 1957 |
Use in Commerce | Mar. 18, 1957 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | No |
Currently 44E | No |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 079011027 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | BARRY A SOLOMON |
Correspondent Name/Address | BARRY A SOLOMON, NOVARTIS CORPORAATION, 564 MORRIS AVE, SUMMIT, NEW JERSEY UNITED STATES 07901-1027 |
Prosecution History
Date | Description |
---|---|
2010-04-10 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
2008-10-16 | CASE FILE IN TICRS |
2000-03-17 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
2000-03-17 | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 |
1999-08-31 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1979-09-08 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
TM Staff and Location Information
Current Location | SCANNING ON DEMAND |
Date in Location | 2008-10-16 |
Register | Principal |
Mark Type | Trademark |
Status | The registration has been renewed. |
Status Date | 2019-12-20 |
Mark Information
Mark Literal Elements | RITALIN |
Standard Character Claim | Yes. The mark consists of standard characters without claim to any particular font style, size, or color. |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Goods and Services
For | PHARMACEUTICAL PREPARATION HAVING A STIMULATING ACTION |
International Class(es) | 005 |
U.S Class(es) | 018 - Primary Class |
Class Status | ACTIVE |
Basis | 1(a) 44(e) |
First Use | Mar. 28, 1944 |
Use in Commerce | Mar. 28, 1944 |
Basis Information (Case Level)
Filed Use | Yes |
Currently Use | Yes |
Filed ITU | No |
Currently ITU | No |
Filed 44D | No |
Currently 44D | No |
Filed 44E | Yes |
Currently 44E | Yes |
Filed 66A | No |
Currently 66A | No |
Filed No Basis | No |
Currently No Basis | No |
Current Owner(s) Information
Owner Name | NOVARTIS CORPORATION |
Owner Address | 564 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
Legal Entity Type | CORPORATION |
State or Country Where Organized | NEW YORK |
Attorney/Correspondence Information
Attorney Name | Maury M. Tepper, III |
Attorney Email Authorized | Yes |
Attorney Primary Email Address | mtepper@wcsr.com |
Fax | 919-861-8913 |
Phone | 919-861-8903 |
Correspondent e-mail | mtepper@teiplaw.com |
Correspondent Name/Address | Maury M. Tepper, III, Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh, NORTH CAROLINA UNITED STATES 27609 |
Correspondent e-mail Authorized | Yes |
Prosecution History
Date | Description |
---|---|
2019-12-20 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
2019-12-20 | REGISTERED AND RENEWED (FIFTH RENEWAL - 10 YRS) |
2019-12-20 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2019-12-20 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2019-11-07 | TEAS SECTION 8 & 9 RECEIVED |
2018-11-22 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2009-10-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2009-09-23 | REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS) |
2009-09-23 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2009-02-17 | ASSIGNED TO PARALEGAL |
2009-02-12 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
2009-02-12 | TEAS SECTION 8 & 9 RECEIVED |
2008-10-07 | CASE FILE IN TICRS |
2004-12-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2004-11-18 | PAPER RECEIVED |
2000-06-09 | REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) |
2000-06-09 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
1999-11-22 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
1989-11-21 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
1989-06-14 | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 |
1969-11-22 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) |
TM Staff and Location Information
Current Location | GENERIC WEB UPDATE |
Date in Location | 2019-12-20 |
Date of last update: 17 Nov 2024
Sources: New York Secretary of State